Polpharma Biologics
Chemicals & Related Products · Poland · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Trzy Lipy 3 Bldg A, Gdansk, Pomeranian V...Phone Number
+48 587709559Website
www.polpharmabiologics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
3
1
1
1
1
About Polpharma Biologics
Polpharma Biologics is a modern biotechnology company specializing in the development and manufacturing of biosimilars and innovative biologics. With state-of-the-art facilities across Europe, they offer customized CDMO services to a range of clients, including large biopharmaceutical companies. Their mission focuses on improving patient access to biologics while reducing healthcare costs through a broad pipeline of biosimilars targeting high-impact diseases. The company is committed to scientific precision and bold partnerships, ensuring that their products reach those in need globally.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Polpharma Biologics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Polpharma Biologics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Polpharma Biologics is spiking on competitors!
Click to see if Polpharma Biologics had a recent Job posting/layoffs
Earning: See what the market has to say on Polpharma Biologics recently announced quarterly report
Funding: Get notified immidiatlly once Polpharma Biologics has new funding data
Check if Polpharma Biologics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Polpharma Biologics launches new products
Congratulate Masked Content for being promoted to Masked Content at Polpharma Biologics
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Polpharma Biologics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Polpharma Biologics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Polpharma Biologics.
Polpharma Biologics Tech Stack
A closer look at the technologies used by Polpharma Biologics
See more technologies
Most Recent Scoops
Event
Product Marketing, Events, Training, Sales, Logistics / Supply Chain, Pharmaceuticals, Clinical Operations, Field Marketing, Manufacturing Operations, Operations
Event
Product Marketing, Events, Training, Sales, Logistics / Supply Chain, Pharmaceuticals, Clinical Operations, Field Marketing, Manufacturing Operations, Operations
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Hiring Plans
Polpharma Biologics has more open roles in Operations than it has had at any time in the past 12 months.
Hiring Plans
Hiring Plans
Hiring Plans
Polpharma Biologics News & Media
Fresenius Kabi inks deal with Polpharma Biologics for Entyvio biosimilar
Vedolizumab is a biologic therapy used to treat Crohn’s disease and ulcerative colitis.Chime Biologics Partners Polpharma Biologics to Advance Global Biosimilar Development
Accelerate Polpharma Biologics biosimilar program from IND to commercial manufacturing Includes a commitment to producing for US FDA BLA submission Expand global market presence through launch in EU and other regions GDAŃSK, Poland and SHANGHAI, April 16, 2025 /PRNewswire/ -- Chime...Polpharma Biologics' investigational biosimilar shows PK/PD comparability to inflammatory bowel disease blockbuster Entyvio®
AMSTERDAM, Feb. 21, 2024 /PRNewswire/ -- Polpharma Biologics, an international biotech company dedicated to the development and manufacturing of biosimilars, today announced topline results demonstrating the pharmacokinetic (PK) and pharmacodynamics (PD) comparability of its biosimilar...Polpharma Biologics, European Biotechnology Company, Selects Box for Cloud Content Management
MUNICH--(BUSINESS WIRE)--Polpharma Biologics, European Biotechnology Company, Selects Box for Cloud Content Management
Read more news
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Polpharma Biologics
Sign Up For FreeTo access detailed company insights
Polpharma Biologics is a modern biotechnology company specializing in the development and manufacturing of biosimilars and innovative biologics. With state-of-the-art facilities across Europe, they offer customized CDMO services to a range of clients, including large biopharmaceutical companies. Their mission focuses on improving patient access to... Read More
